World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
40300
World Ranking
7345
National Ranking
3845

Overview

Douglas A. Jabs is affiliated with Johns Hopkins University School of Medicine in the United States. Their research is primarily situated within the field of Medicine, with a significant focus on Ophthalmology. The scope of their work also encompasses related subfields including Rheumatology, Infectious Diseases, Epidemiology, and Pulmonary and Respiratory Medicine.

Their publications cover a range of topics, particularly:

  • Ocular Diseases and Behçet's Syndrome
  • Retinal and Optic Conditions
  • Retinal Diseases and Treatments
  • Systemic Lupus Erythematosus Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Vasculitis and related conditions

Douglas A. Jabs has contributed to several recent papers, including:

  • Early Outpatient Treatment for Covid-19 with Convalescent Plasma (2022), published in New England Journal of Medicine
  • Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1 (2020), published in Ophthalmology
  • Uveitis for the non-ophthalmologist (2021), published in BMJ
  • Risk of Cataract Development among Children with Juvenile Idiopathic Arthritis-Related Uveitis Treated with Topical Corticosteroids (2020), published in Ophthalmology
  • Seven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Results (2020), published in Ophthalmology

Their frequent coauthors include:

  • Jennifer E. Thorne
  • John H. Kempen
  • Sapna Gangaputra
  • James T. Rosenbaum
  • Eric B. Suhler

Among the venues where they have published regularly are:

  • American Journal of Ophthalmology
  • Ophthalmology
  • Ocular Immunology and Inflammation
  • bioRxiv (Cold Spring Harbor Laboratory)
  • JAMA Ophthalmology

Best Publications

  • Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

    Douglas A Jabs;Robert B Nussenblatt;James T Rosenbaum

  • Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia

    GJ Anhalt;SC Kim;JR Stanley;NJ Korman

  • Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

    Douglas A. Jabs;James T. Rosenbaum;C.Stephen Foster;Gary N. Holland

  • Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

    Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston

  • Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection

    Peter W. Hunt;Elizabeth Sinclair;Benigno Rodriguez;Carey Shive

  • Thalidomide for the treatment of chronic graft-versus-host disease.

    G B Vogelsang;E R Farmer;A D Hess;V Altamonte

  • Cytomegalovirus retinitis and acquired immunodeficiency syndrome.

    Douglas A. Jabs;Cheryl Enger;John G. Bartlett

  • Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.

    Grace Levy-Clarke;Douglas A. Jabs;Russell W. Read;James T. Rosenbaum

  • Ocular Involvement in Chronic Sarcoidosis

    Douglas A. Jabs;Carol J. Johns

  • Episcleritis and scleritis: clinical features and treatment results.

    Douglas A. Jabs;Abdulbaki Mudun;J.P. Dunn;Marta J. Marsh

  • Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.

    Justine R. Smith;Ralph D. Levinson;Gary N. Holland;Douglas A. Jabs

  • Ocular manifestations of HIV infection.

    DA Jabs

  • Randomized Comparison of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Implant for Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment Trial

    John H. Kempen;Michael M. Altaweel;Janet T. Holbrook;Douglas A. Jabs

  • Ocular Manifestations of Acquired Immune Deficiency Syndrome

    Douglas A. Jabs;W. Richard Green;Robin Fox;B. Frank Polk

  • Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

    R. A. Lewis;P. Clogston;Victor Fainstein;R. Gross

  • Methotrexate for Ocular Inflammatory Diseases

    Sapna Gangaputra;Sapna Gangaputra;Craig W. Newcomb;Teresa L. Liesegang;R. Oktay Kaçmaz

  • Azathioprine for Ocular Inflammatory Diseases

    Sirichai Pasadhika;John H. Kempen;Craig W. Newcomb;Teresa L. Liesegang

  • Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy.

    David A. Palay;Paul Sternberg;Janet Davis;Hilel Lewis

  • Cyclosporine for Ocular Inflammatory Diseases

    R. Oktay Kaçmaz;John H. Kempen;Craig Newcomb;Ebenezer Daniel;Ebenezer Daniel

  • Methotrexate for Ocular Inflammatory Diseases

    G. A. Levy-Clarke;S. Gangaputra;C. W. Newcomb;D. A. Jabs

Frequent Co-Authors

Jennifer E. Thorne
Jennifer E. Thorne Johns Hopkins University
James T. Rosenbaum
James T. Rosenbaum Oregon Health & Science University
Robert B. Nussenblatt
Robert B. Nussenblatt National Institutes of Health
C. Stephen Foster
C. Stephen Foster Harvard University
Gary N. Holland
Gary N. Holland University of California, Los Angeles
Susan Lightman
Susan Lightman University College London
Mark A. Jacobson
Mark A. Jacobson University of California, San Francisco
Janet L. Davis
Janet L. Davis University of Miami
Grant James Anhalt
Grant James Anhalt Johns Hopkins University
Robert L. Murphy
Robert L. Murphy Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medical careers but seeking flexible or alternative paths, there are several related online degrees worth considering. A health administration degree is an excellent option for those interested in the business and management side of healthcare. This degree can prepare graduates for roles in hospital administration, health services management, and more.

Many working professionals opt for a master's degree to advance their career. The most affordable online mha programs offer accessible pathways for those looking to step into leadership roles within healthcare organizations without putting their career on hold.

For nurses aiming to reach the pinnacle of clinical practice, the cheapest dnp online programs provide doctoral-level education in nursing practice. These programs help nurses gain skills for advanced practice roles, leadership, and clinical research.

Aspiring pharmacists can explore the option of an online pharmacist degree. This flexible degree path prepares graduates for licensure and practice in pharmacy, with many programs designed to accommodate working students.

Best Scientists Citing Douglas A. Jabs

Trending Scientists